Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad) Buy GEAR Stock  Free GEAR Stock Alerts

Revelyst (GEAR) Financials

Revelyst logo
$20.08 +0.86 (+4.47%)
As of 01/3/2025
Compare
Annual Income Statements for Revelyst

Annual Income Statements for Revelyst

This table shows Revelyst's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 -242 -337 78
Consolidated Net Income / (Loss)		 -242 -337 78
Net Income / (Loss) Continuing Operations		 -242 -337 78
Total Pre-Tax Income 		-265 -366 102
Total Operating Income		 -263 -368 102
Total Gross Profit		 373 377 397
Total Revenue		 1,309 1,339 1,322
Operating Revenue		 1,309 1,339 1,322
Total Cost of Revenue		 936 963 925
Operating Cost of Revenue		 936 963 925
Total Operating Expenses		 636 745 295
Selling, General & Admin Expense		 375 334 274
Research & Development Expense		 42 37 21
Impairment Charge		 219 374 0.00
Total Other Income / (Expense), net		 -1.87 2.30 0.00
Interest & Investment Income		 0.12 0.17 0.00
Other Income / (Expense), net		 -1.99 2.12 0.00
Income Tax Expense		 -22 -29 24
Weighted Average Basic Shares Outstanding		 1K - -
Weighted Average Diluted Shares Outstanding		 1K - -
Weighted Average Basic & Diluted Shares Outstanding		 1K - -

Quarterly Income Statements for Revelyst

This table shows Revelyst's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q2 2024 Q1 2024
Period end date 9/30/2024 6/30/2024 9/24/2023 6/25/2023
Net Income / (Loss) Attributable to Common Shareholders		 4.56 -1.96 -4.34 -5.36
Consolidated Net Income / (Loss)		 4.56 -1.29 -4.34 -5.36
Net Income / (Loss) Continuing Operations		 4.56 -1.29 -4.34 -5.36
Total Pre-Tax Income 		4.59 -0.81 -5.93 -5.80
Total Operating Income		 4.32 -1.50 -4.80 -5.30
Total Gross Profit		 98 81 94 95
Total Revenue		 315 274 333 321
Operating Revenue		 315 274 333 321
Total Cost of Revenue		 217 193 239 227
Operating Cost of Revenue		 217 193 239 227
Total Operating Expenses		 94 102 99 100
Selling, General & Admin Expense		 84 91 88 90
Research & Development Expense		 9.51 11 10 10
Other Operating Expenses / (Income)		 0.87 - 0.00 -
Total Other Income / (Expense), net		 0.27 20 -1.14 -0.50
Interest & Investment Income		 0.01 0.01 0.04 0.04
Other Income / (Expense), net		 0.26 20 -1.17 -0.54
Income Tax Expense		 0.03 0.47 -1.59 -0.44
Weighted Average Basic Shares Outstanding		 1K 1K - -
Weighted Average Diluted Shares Outstanding		 1K 1K - -
Weighted Average Basic & Diluted Shares Outstanding		 1K 1K - -

Annual Cash Flow Statements for Revelyst

This table details how cash moves in and out of Revelyst's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Net Change in Cash & Equivalents		 7.41 8.26 5.52
Net Cash From Operating Activities		 179 64 -31
Net Cash From Continuing Operating Activities		 179 64 -31
Net Income / (Loss) Continuing Operations		 -242 -337 78
Consolidated Net Income / (Loss)		 -242 -337 78
Depreciation Expense		 21 19 16
Amortization Expense		 50 44 26
Non-Cash Adjustments To Reconcile Net Income		 229 387 13
Changes in Operating Assets and Liabilities, net		 122 -50 -164
Net Cash From Investing Activities		 -30 -774 -559
Net Cash From Continuing Investing Activities		 -30 -774 -559
Purchase of Property, Plant & Equipment		 -14 -13 -13
Acquisitions		 -16 -762 -545
Sale of Property, Plant & Equipment		 0.13 0.04 0.03
Net Cash From Financing Activities		 -142 719 595
Net Cash From Continuing Financing Activities		 -142 719 595
Other Financing Activities, net		 -142 719 595
Effect of Exchange Rate Changes		 0.30 -0.32 -0.07

Quarterly Cash Flow Statements for Revelyst

This table details how cash moves in and out of Revelyst's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q2 2024 Q1 2024
Period end date 9/30/2024 6/30/2024 9/24/2023 6/25/2023
Net Change in Cash & Equivalents		 -8.00 6.79 -4.52 15
Net Cash From Operating Activities		 14 27 36 63
Net Cash From Continuing Operating Activities		 14 27 36 63
Net Income / (Loss) Continuing Operations		 4.56 -1.29 -4.34 -5.36
Consolidated Net Income / (Loss)		 4.56 -1.29 -4.34 -5.36
Depreciation Expense		 3.81 4.31 5.17 4.96
Amortization Expense		 12 12 13 13
Non-Cash Adjustments To Reconcile Net Income		 2.56 -9.35 3.75 0.39
Changes in Operating Assets and Liabilities, net		 -9.76 21 19 50
Net Cash From Investing Activities		 2.36 33 -3.18 -3.33
Net Cash From Continuing Investing Activities		 2.36 33 -3.18 -3.33
Purchase of Property, Plant & Equipment		 -3.78 -0.50 -3.19 -3.45
Divestitures		 6.14 33 - 0.00
Net Cash From Financing Activities		 -25 -53 -36 -45
Net Cash From Continuing Financing Activities		 -25 -53 -36 -45
Other Financing Activities, net		 -25 -53 -36 -45
Effect of Exchange Rate Changes		 1.14 -0.27 -1.13 0.43

Annual Balance Sheets for Revelyst

This table presents Revelyst's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023
Period end date 3/31/2024 3/31/2023
Total Assets		 1,575 1,951
Total Current Assets		 557 664
Cash & Equivalents		 23 16
Accounts Receivable		 209 202
Inventories, net		 294 404
Prepaid Expenses		 23 37
Current Deferred & Refundable Income Taxes		 1.44 0.00
Other Current Assets		 6.71 5.74
Plant, Property, & Equipment, net		 61 71
Total Noncurrent Assets		 956 1,216
Goodwill		 232 380
Intangible Assets		 569 675
Other Noncurrent Operating Assets		 154 161
Total Liabilities & Shareholders' Equity		 1,575 1,951
Total Liabilities		 341 365
Total Current Liabilities		 206 204
Accounts Payable		 87 67
Current Employee Benefit Liabilities		 20 25
Other Taxes Payable		 13 13
Other Current Liabilities		 87 97
Total Noncurrent Liabilities		 135 161
Noncurrent Deferred & Payable Income Tax Liabilities		 13 28
Other Noncurrent Operating Liabilities		 122 134
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 1,234 1,586
Total Preferred & Common Equity		 1,234 1,586
Total Common Equity		 1,234 1,586
Accumulated Other Comprehensive Income / (Loss)		 -5.61 -8.16
Other Equity Adjustments		 1,239 1,594

Quarterly Balance Sheets for Revelyst

This table presents Revelyst's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025
Period end date 9/30/2024 6/30/2024
Total Assets		 1,501 1,527
Total Current Assets		 530 541
Cash & Equivalents		 22 30
Accounts Receivable		 211 196
Inventories, net		 261 283
Prepaid Expenses		 27 23
Current Deferred & Refundable Income Taxes		 1.97 0.69
Other Current Assets		 6.43 7.76
Plant, Property, & Equipment, net		 45 49
Total Noncurrent Assets		 926 937
Goodwill		 232 232
Intangible Assets		 543 555
Other Noncurrent Operating Assets		 151 149
Total Liabilities & Shareholders' Equity		 1,501 1,527
Total Liabilities		 335 344
Total Current Liabilities		 210 216
Accounts Payable		 89 85
Current Employee Benefit Liabilities		 20 18
Other Taxes Payable		 11 11
Other Current Liabilities		 90 101
Total Noncurrent Liabilities		 125 127
Noncurrent Deferred & Payable Income Tax Liabilities		 12 13
Other Noncurrent Operating Liabilities		 113 114
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 1,166 1,183
Total Preferred & Common Equity		 1,166 1,183
Total Common Equity		 1,166 1,183
Accumulated Other Comprehensive Income / (Loss)		 -5.40 -5.55
Other Equity Adjustments		 1,171 1,188

Annual Metrics And Ratios for Revelyst

This table displays calculated financial ratios and metrics derived from Revelyst's official financial filings.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Growth Metrics		 - - -
Revenue Growth		 -2.28% 1.28% 0.00%
EBITDA Growth		 35.87% -309.99% 0.00%
EBIT Growth		 27.64% -457.36% 0.00%
NOPAT Growth		 28.60% -428.80% 0.00%
Net Income Growth		 28.03% -529.54% 0.00%
EPS Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 180.83% 306.34% 0.00%
Free Cash Flow Firm Growth		 109.59% 0.00% 0.00%
Invested Capital Growth		 -22.88% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 28.52% 28.13% 30.05%
EBITDA Margin		 -14.85% -22.63% 10.92%
Operating Margin		 -20.08% -27.49% 7.74%
EBIT Margin		 -20.24% -27.33% 7.74%
Profit (Net Income) Margin		 -18.51% -25.14% 5.93%
Tax Burden Percent		 91.52% 92.02% 76.52%
Interest Burden Percent		 99.96% 99.95% 100.00%
Effective Tax Rate		 0.00% 0.00% 23.48%
Return on Invested Capital (ROIC)		 -13.23% -32.83% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 289.59% 983.37% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -3.95% -9.64% 0.00%
Return on Equity (ROE)		 -17.19% -42.46% 0.00%
Cash Return on Invested Capital (CROIC)		 12.60% -232.83% 0.00%
Operating Return on Assets (OROA)		 -15.03% -18.76% 0.00%
Return on Assets (ROA)		 -13.75% -17.26% 0.00%
Return on Common Equity (ROCE)		 -17.19% -42.46% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -19.64% -21.23% 0.00%
Net Operating Profit after Tax (NOPAT)		 -184 -258 78
NOPAT Margin		 -14.06% -19.24% 5.93%
Net Nonoperating Expense Percent (NNEP)		 -302.82% -1,016.20% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -14.91% -16.25% -
Cost of Revenue to Revenue		 71.48% 71.87% 69.95%
SG&A Expenses to Revenue		 28.67% 24.93% 20.70%
R&D to Revenue		 3.21% 2.74% 1.61%
Operating Expenses to Revenue		 48.60% 55.62% 22.31%
Earnings before Interest and Taxes (EBIT)		 -265 -366 102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -194 -303 144
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00
Financial Leverage		 -0.01 -0.01 0.00
Leverage Ratio		 1.25 1.23 0.00
Compound Leverage Factor		 1.25 1.23 0.00
Debt to Total Capital		 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 0.00%
Debt to EBITDA		 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 2.70 3.26 0.00
Quick Ratio		 1.13 1.07 0.00
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 175 -1,828 0.00
Operating Cash Flow to CapEx		 1,290.60% 497.39% -236.65%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.74 0.69 0.00
Accounts Receivable Turnover		 6.36 6.64 0.00
Inventory Turnover		 2.68 2.38 0.00
Fixed Asset Turnover		 19.71 18.77 0.00
Accounts Payable Turnover		 12.18 14.45 0.00
Days Sales Outstanding (DSO)		 57.36 55.01 0.00
Days Inventory Outstanding (DIO)		 136.03 153.05 0.00
Days Payable Outstanding (DPO)		 29.97 25.26 0.00
Cash Conversion Cycle (CCC)		 163.41 182.80 0.00
Capital & Investment Metrics		 - - -
Invested Capital		 1,211 1,570 0.00
Invested Capital Turnover		 0.94 1.71 0.00
Increase / (Decrease) in Invested Capital		 -359 1,570 0.00
Enterprise Value (EV)		 0.00 0.00 0.00
Market Capitalization		 0.00 0.00 0.00
Book Value per Share		 $1,233,848.00 $0.00 $0.00
Tangible Book Value per Share		 $432,389.00 $0.00 $0.00
Total Capital		 1,234 1,586 0.00
Total Debt		 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00
Net Debt		 -23 -16 0.00
Capital Expenditures (CapEx)		 14 13 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 328 444 0.00
Debt-free Net Working Capital (DFNWC)		 351 460 0.00
Net Working Capital (NWC)		 351 460 0.00
Net Nonoperating Expense (NNE)		 58 79 -0.00
Net Nonoperating Obligations (NNO)		 -23 -16 0.00
Total Depreciation and Amortization (D&A)		 70 63 42
Debt-free, Cash-free Net Working Capital to Revenue		 25.07% 33.19% 0.00%
Debt-free Net Working Capital to Revenue		 26.82% 34.35% 0.00%
Net Working Capital to Revenue		 26.82% 34.35% 0.00%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 1K 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 1K 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1K 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -31 4.35 78
Normalized NOPAT Margin		 -2.36% 0.32% 5.93%
Pre Tax Income Margin		 -20.23% -27.31% 7.74%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Revelyst

This table displays calculated financial ratios and metrics derived from Revelyst's official financial filings.

Metric Q2 2025 Q1 2025 Q2 2024 Q1 2024
Period end date 9/30/2024 6/30/2024 9/24/2023 6/25/2023
Growth Metrics		 - - - -
Revenue Growth		 -5.36% -14.69% 0.00% 0.00%
EBITDA Growth		 76.76% 195.88% 0.00% 0.00%
EBIT Growth		 176.67% 409.70% 0.00% 0.00%
NOPAT Growth		 227.79% 71.64% 0.00% 0.00%
Net Income Growth		 204.93% 76.00% 0.00% 0.00%
EPS Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -62.33% -57.43% 0.00% 0.00%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 14.86% 0.00% 3.54% 0.00%
EBITDA Q/Q Growth		 -40.24% 0.00% 0.04% 0.00%
EBIT Q/Q Growth		 -74.68% 0.00% -2.28% 0.00%
NOPAT Q/Q Growth		 508.12% 0.00% 9.44% 0.00%
Net Income Q/Q Growth		 454.28% 0.00% 18.96% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -49.38% 0.00% -42.80% 0.00%
Free Cash Flow Firm Q/Q Growth		 1.23% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -0.77% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - -
Gross Margin		 31.21% 29.68% 28.17% 29.47%
EBITDA Margin		 6.61% 12.70% 3.54% 3.66%
Operating Margin		 1.37% -0.55% -1.44% -1.65%
EBIT Margin		 1.45% 6.59% -1.79% -1.82%
Profit (Net Income) Margin		 1.45% -0.47% -1.30% -1.67%
Tax Burden Percent		 99.26% 157.99% 73.17% 92.44%
Interest Burden Percent		 100.26% -4.50% 99.38% 99.28%
Effective Tax Rate		 0.74% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 2.96% -0.84% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.52% 0.74% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -0.01% -0.02% 0.00% 0.00%
Return on Equity (ROE)		 2.95% -0.86% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 1.20% 5.45% 0.00% 0.00%
Return on Assets (ROA)		 1.20% -0.39% 0.00% 0.00%
Return on Common Equity (ROCE)		 2.95% -0.86% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -19.67% -20.14% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 4.29 -1.05 -3.36 -3.71
NOPAT Margin		 1.36% -0.38% -1.01% -1.15%
Net Nonoperating Expense Percent (NNEP)		 2.44% -1.58% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 0.37% -0.09% - -
Cost of Revenue to Revenue		 68.79% 70.32% 71.83% 70.53%
SG&A Expenses to Revenue		 26.54% 33.29% 26.52% 27.89%
R&D to Revenue		 3.02% 3.84% 3.10% 3.22%
Operating Expenses to Revenue		 29.84% 37.12% 29.61% 31.12%
Earnings before Interest and Taxes (EBIT)		 4.58 18 -5.97 -5.84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 21 35 12 12
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 -0.02 -0.03 0.00 0.00
Leverage Ratio		 1.29 1.29 0.00 0.00
Compound Leverage Factor		 1.29 -0.06 0.00 0.00
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 0.00% 0.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 2.52 2.50 0.00 0.00
Quick Ratio		 1.11 1.04 0.00 0.00
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 -1,140 -1,154 0.00 0.00
Operating Cash Flow to CapEx		 359.21% 5,423.43% 1,134.73% 1,896.75%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.83 0.83 0.00 0.00
Accounts Receivable Turnover		 5.89 6.44 0.00 0.00
Inventory Turnover		 3.36 3.19 0.00 0.00
Fixed Asset Turnover		 27.39 25.62 0.00 0.00
Accounts Payable Turnover		 9.90 10.59 0.00 0.00
Days Sales Outstanding (DSO)		 62.00 56.71 0.00 0.00
Days Inventory Outstanding (DIO)		 108.50 114.58 0.00 0.00
Days Payable Outstanding (DPO)		 36.88 34.47 0.00 0.00
Cash Conversion Cycle (CCC)		 133.61 136.82 0.00 0.00
Capital & Investment Metrics		 - - - -
Invested Capital		 1,144 1,153 0.00 0.00
Invested Capital Turnover		 2.17 2.19 0.00 0.00
Increase / (Decrease) in Invested Capital		 1,144 1,153 0.00 0.00
Enterprise Value (EV)		 0.00 0.00 0.00 0.00
Market Capitalization		 0.00 0.00 0.00 0.00
Book Value per Share		 $1,165,913.00 $1,182,818.00 $0.00 $0.00
Tangible Book Value per Share		 $391,112.00 $395,612.00 $0.00 $0.00
Total Capital		 1,166 1,183 0.00 0.00
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 -22 -30 0.00 0.00
Capital Expenditures (CapEx)		 3.78 0.50 3.18 3.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 298 295 0.00 0.00
Debt-free Net Working Capital (DFNWC)		 320 324 0.00 0.00
Net Working Capital (NWC)		 320 324 0.00 0.00
Net Nonoperating Expense (NNE)		 -0.27 0.23 0.98 1.65
Net Nonoperating Obligations (NNO)		 -22 -30 0.00 0.00
Total Depreciation and Amortization (D&A)		 16 17 18 18
Debt-free, Cash-free Net Working Capital to Revenue		 23.96% 23.35% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 25.71% 25.71% 0.00% 0.00%
Net Working Capital to Revenue		 25.71% 25.71% 0.00% 0.00%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 1K 1K 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 1K 1K 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1K 1K 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 4.29 -1.05 -3.36 -3.71
Normalized NOPAT Margin		 1.36% -0.38% -1.01% -1.15%
Pre Tax Income Margin		 1.46% -0.30% -1.78% -1.80%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Revelyst's Financials

When does Revelyst's financial year end?

According to the most recent income statement we have on file, Revelyst's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Revelyst's net income changed over the last 2 years?

Revelyst's net income appears to be on an upward trend, with a most recent value of -$242.28 million in 2024, falling from $78.38 million in 2022. The previous period was -$336.66 million in 2023.

What is Revelyst's operating income?
Revelyst's total operating income in 2024 was -$262.87 million, based on the following breakdown:
  • Total Gross Profit: $373.22 million
  • Total Operating Expenses: $636.09 million
How has Revelyst revenue changed over the last 2 years?

Over the last 2 years, Revelyst's total revenue changed from $1.32 billion in 2022 to $1.31 billion in 2024, a change of -1.0%.

How much debt does Revelyst have?

Revelyst's total liabilities were at $341.02 million at the end of 2024, a 6.5% decrease from 2023, and a 6.5% decrease since 2023.

How much cash does Revelyst have?

In the past 1 years, Revelyst's cash and equivalents has ranged from $15.54 million in 2023 to $22.95 million in 2024, and is currently $22.95 million as of their latest financial filing in 2024.

How has Revelyst's book value per share changed over the last 2 years?

Over the last 2 years, Revelyst's book value per share changed from 0.00 in 2022 to 1,233,848.00 in 2024, a change of 123,384,800.0%.


Related Companies

This page (NYSE:GEAR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Warning: Prepare to Be Shocked by These Payouts
There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...
Investors Alley | Sponsored
The Prophet's Newest Prediction
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...
Stansberry Research | Sponsored
A new financial chapter
Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...
Porter & Company | Sponsored
The Secret Map of America, Declassified…
Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...
Banyan Hill Publishing | Sponsored
Trump’s Bitcoin Reserve is No Accident…
How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...
Crypto 101 Media | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Silver Is the New Oil—And the World’s Running Dry
Elon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...
Priority Gold | Sponsored